Atlas Trials

Effect of Metformin on ABCB1 and AMPK Expression in Adolescents With Newly Diagnosed Acute Lymphoblastic Leukemia

Clinical trial NCT05326984 · UNKNOWN

Trial details

NCT number
NCT05326984
Sponsor
Hospital General de Mexico
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Acute Lymphoblastic Leukemia
Start date
2021-02-09
Primary completion
2023-12-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.